PECAM1 and neoplasm: To investigate the cause of decreased tumor growth in CEMIP negative cells in vivo, we examined CEMIP expressing and CEMIP negative tumors by immunostaining for markers of apoptosis (cleaved caspase-3), proliferation (Ki-67), leukocyte infiltration (CD45), and vascularization (CD31).